Can Merck Produce a Growth Stimulant?

As rivals look beyond their own labs for new drugs, Merck prefers inhouse R&D. Better hope there are blockbusters in the pipeline

By Amy Tsao

To continue reading this article you must be a Bloomberg Professional Service Subscriber.